Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
PharmaNutrition is Scopus-indexed (Q2, CiteScore 5.1), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2213-4344Verify ISSN ↗2542-520XVerify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$3,300 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Food Science | 141 / 420 | 66th | Q2 |
| Pharmacology (medical) | 96 / 278 | 65th | Q2 |
| Pharmacology | 136 / 328 | 58th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q2, CiteScore 5.1.
PharmaNutrition is Q2 in Food Science (rank 141 of 420), Q2 in Pharmacology (medical) (rank 96 of 278) and Q2 in Pharmacology (rank 136 of 328), by CiteScore 2025.
PharmaNutrition is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.601, quartile Q2, with an H-index of 37.
The publisher lists an article processing charge of about US$3,300 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
PharmaNutrition is published by Elsevier B.V. Its print ISSN is 2213-4344 and its online ISSN is 2542-520X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
PharmaNutrition has an h-index of 40 and a 2-year mean of 2.92 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q2. On 2-year citations it ranks #144 of 407 Scopus journals in Food Science.
PharmaNutrition published 34 papers in 2025; its busiest recent year was 2020 with 69. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2024–2026), authors are most often from India (32.3%), China (16.8%) and Iran (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.